Oligoclonal expansions of mucosal T cells in Crohn's disease predominate in NKG2D-expressing CD4 T cells

Mucosal Immunology

Volumn 7, Issue 2, 2014, Pages 325-334

  Camus, M ^a   Esses, S ^b   Pariente, B ^a,c   Le Bourhis, L ^a   Douay, C ^a,d   Chardiny, V ^a   Mocan, I ^a   Benlagha, K ^a,d   Clave, E ^a,d   Toubert, A ^a,d   Mayer, L ^b   Allez, M ^a,c,d  

^a INSERM   (France)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL KILLER CELL RECEPTOR NKG2D; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUM; INTESTINE MUCOSA; MALE; MIDDLE AGED; MUCOSA INFLAMMATION; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RELAPSE; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CROHN DISEASE; FEMALE; HUMANS; ILEUM; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECURRENCE; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 84895113866     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.51     Document Type: Article

References (42)

1. Podolsky,D.K. Inflammatory bowel disease. N. Engl. J. Med. 347, 417-429 (2002).
2. Buhner, S. et al. Genetic basis for increased intestinal permeability in families with Crohn's disease: Role of CARD15 3020insC mutation+. Gut 55, 342-347 (2006).
3. Wehkamp, J. et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA 102, 18129-18134 (2005).
4. Darfeuille-Michaud, A. et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127, 412-421 (2004).
5. Xavier, R.J. & Podolsky, D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434 (2007).
6. Cobrin,G.M. & Abreu, M.T. Defects in mucosal immunity leading to Crohn's disease. Immunol. Rev. 206, 277-295 (2005).
7. Mowat, A.M. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3, 331-341 (2003).
8. Allez, M. & Mayer, L. Regulatory Tcells: Peace keepers in the gut. Inflamm Bowel Dis. 10, 666-676 (2004).
9. Bouma, G. & Strober, W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3, 521-533 (2003).
10. Barrett, J.C. et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40, 955-962 (2008).
11. Consortium WTCC.. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
12. Hugot, J.P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
13. Hisamatsu, T. et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124, 993-1000 (2003).
14. Smith, A.M. et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J. Exp. Med. 206, 1883-1897 (2009).
15. Elson, C.O. et al. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol. Rev. 206, 260-276 (2005).
16. Probert, C.S. et al. Repertoire of the alpha beta T cell receptor in the intestine. Immunol. Rev. 215, 215-225 (2007).
17. Ferrante, M. et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 56, 1394-1403 (2007).
18. Allez, M. et al. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Gastroenterology 132, 2346-2358 (2007).
19. Groh, V. et al. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2, 255-260 (2001).
20. Raulet, D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3, 781-790 (2003).
21. Groh,V. et al. Stimulation of Tcell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. U S A 100, 9452-9457 (2003).
22. Saez-Borderias, A. et al. Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. Eur. J. Immunol. 36, 3198-3206 (2006).
23. Vankayalapati, R. et al. Role ofNKcell activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 175, 4611-4617 (2005).
24. Pariente, B. et al. Activation of the receptor NKG2D leads to production of Th17 cytokines in CD4+ T cells of patients with Crohn's disease. Gastroenterology 141, 217-226. 226.e1-2 (2011).
25. Jorgensen, J.L. et al. Mapping T cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 355, 224-230 (1992).
26. Garboczi, D.N. et al. Structure of the complex between human T cell receptor, viral peptide and HLA-A2. Nature 384, 134-141 (1996).
27. Gulwani-Akolkar, B. et al. CD4+ cell oligoclonality in Crohn's disease: Evidence for an antigen-specific response. Hum. Immunol. 48, 114-124 (1996).
28. Gulwani-Akolkar, B. et al. Selective expansion of specific Tcell receptors in the inflamed colon of Crohn's disease. J. Clin. Invest. 98, 1344-1354 (1996).
29. Gulwani-Akolkar, B. et al. Crohn's disease is accompanied by changes in the CD4+, but not CD8+, Tcell receptor BV repertoire of lamina propria lymphocytes. Clin. Immunol. Immunopathol. 77, 95-106 (1995).
30. ECCO. Guidelines dans JCC.
31. Sorrentino, D., Paviotti, A., Terrosu, G., Avellini, C., Geraci, M. & Zarifi, D. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease. Clin. Gastroenterol. Hepatol. 8, 591-599 (2010).
32. Regueiro, M. et al. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology 136, 441-450 (2009).
33. Papamichael, K., Archavlis, E., Lariou, C. & Mantzaris, G.J. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: A prospective, two-year, single center, pilot study. J. Crohns. Colitis. 6, 924-931 (2012).
34. Blumberg, R.S. et al. Human intestinal intraepithelial lymphocytes are derived from a limited number of T cell clones that utilize multiple V beta T cell receptor genes. J. Immunol. 150, 5144-5153 (1993).
35. Nancey, S. et al. CD8+ cytotoxic Tcells induce relapsing colitis in normal mice. Gastroenterology 131, 485-496 (2006).
36. Meresse, B. et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21, 357-366 (2004).
37. Allez, M. et al. Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology 123, 1516-1526 (2002).
38. Lim, A. et al. Combination of MHC-peptide multimer-based T cell sorting with the Immunoscope permits sensitive ex vivo quantitation and follow-up of human CD8+ T cell immune responses. J. Immunol. Methods 261, 177-194 (2002).
39. Clave, E. et al. Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation. Blood 113, 6477-6484 (2009).
40. Wei, S. et al. The extent of the human germline Tcell receptor V beta gene segment repertoire. Immunogenetics 40, 27-36 (1994).
41. Shapiro, S.S. & Wilk, M.B. An analysis of variance test for normality (complete samples). Biometrika 52, 591-611 (1965).
42. Toyonaga, B. et al. Organization and sequences of the diversity, joining, and constant region genes of the human Tcell receptor beta chain. Proc. Natl. Acad. Sci. USA 82, 8624-8628 (1985).